China’s Medical Technology Innovation and its Implication for Global Health

In recent years, China’s innovations in the healthcare sector, particularly in medical devices and pharmaceuticals, have grown significantly. With its rapid advancements in innovative medical technology, China is emerging as a key player in addressing global health challenges, particularly in low- and middle-income countries (LMICs).

Many LMICs continue to face structural barriers such as insufficient healthcare infrastructure, limited availability of affordable treatment and diagnostic tools, and a rising burden of non-communicable diseases. In this context, China’s expanding capacity in medical innovation offers an opportunity to explore new pathways toward more sustainable and inclusive healthcare solutions.

This session will convene a diverse group of stakeholders—ranging from representatives of China’s innovative health technology sector to development partners, healthcare professionals, and policymakers—to examine the current landscape of Chinese medical innovations and how they could contribute to addressing health challenges in LMICs. Discussions will focus on the drivers and barriers influencing the adoption of these technologies in developing contexts, and examine the policy frameworks and strategies that can facilitate equitable and effective integration into global health systems.